Optimal value of CA19-9 determined by KRAS-mutated circulating tumor DNA contributes to the prediction of prognosis in pancreatic cancer patients.
Sci Rep
; 11(1): 20797, 2021 10 21.
Article
in En
| MEDLINE
| ID: mdl-34675229
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Proto-Oncogene Proteins p21(ras)
/
CA-19-9 Antigen
/
Carcinoma, Ductal
/
Circulating Tumor DNA
/
Mutation
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
En
Journal:
Sci Rep
Year:
2021
Document type:
Article
Affiliation country:
Japan
Country of publication:
United kingdom